# Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects

> **NCT05354752** · PHASE1 · COMPLETED · sponsor: **Jiangsu vcare pharmaceutical technology co., LTD** · enrollment: 60 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** VC005 tablets
- **DRUG:** VC005 Placebo tablets

## Key facts

- **NCT ID:** NCT05354752
- **Lead sponsor:** Jiangsu vcare pharmaceutical technology co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-18
- **Primary completion:** 2022-11-02
- **Final completion:** 2022-11-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354752, "Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05354752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*